Spire (activity tracker)
Manufacturer | Spire Inc. |
---|---|
Website | https://spire.io/ |
Spire is a wearable activity tracker worn on the waistband or bra strap designed to analyze breath rates to determine levels of tension, calm, or focus.[1]
Description
Spire launched preorders on June 17, 2014.[2] The app (required to view and interpret the data it records) is currently compatible with Apple iOS devices running iOS 8.2 or higher. The device resembles a grey stone with a large clip on the side, and charges wirelessly with an included charging pad.[3]
Reception
Spire has been discussed in articles by Popular Science, TechCrunch, and USA today.[4][5][6]
One review have found its exercise tracking inaccurate.[7] USA Today and TechCrunch point out a negative to the device being that it can be worn only on the waistband or bra strap.[5][6]
Function
Through monitoring breath rates, Spire claims to improve the user's mental and physical health.[1] Cofounder Neema Moraveji designed the device from his work in respiratory psychophysiology at Stanford University’s Calming Technology Lab.[8][9]
Specifications
- Stone: 32 mm x 44 mm x 14 mm [3]
- Clasp: 52 mm x 12.5 mm [3]
- Charger: 89 mm x 89 mm [3]
- Battery Life: 7 days [3]
References
- 1 2 "Activity tracking for healthy body and mind.". Spire.io. Retrieved 7 October 2014.
- ↑ "Spire's Launch: The First 48hrs". Spire Blog. Retrieved 7 October 2014.
- 1 2 3 4 5 "Activity tracking for healthy body and mind.". Spire.io. Retrieved 7 October 2014.
- ↑ "A Pocket Fitness Tracker That Studies Your Breathing". Popular Science. Retrieved 7 October 2014.
- 1 2 "Meet "Spire", The Wearable Breath Tracker That Calms You Down". TechCrunch. 17 June 2014. Retrieved 7 October 2014.
- 1 2 "What's hot: Step up to the latest fitness trackers". Usatoday.com. Retrieved 7 October 2014.
- ↑ "Spire activity tracker review". December 24, 2014. Retrieved 22 October 2015.
- ↑ "Neema Moraveji: Projects". Moraveji.org. Retrieved 7 October 2014.
- ↑ "Calming Technology". Calmingtechnology.org. Retrieved 7 October 2014.